SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-23-001792
Filing Date
2023-02-13
Accepted
2023-02-13 16:06:21
Documents
17
Period of Report
2023-02-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A maia-8ka_20230213.htm   iXBRL 8-K/A 45637
2 EX-99.1 maia-ex991_6.htm EX-99.1 27801
3 GRAPHIC guru4q1pmcs2000001.jpg GRAPHIC 31144
4 GRAPHIC guru4q1pmcs2000004.jpg GRAPHIC 32280
5 GRAPHIC guru4q1pmcs2000002.jpg GRAPHIC 141593
6 GRAPHIC guru4q1pmcs2000005.jpg GRAPHIC 20311
  Complete submission text file 0001564590-23-001792.txt   527997

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA maia-20230213.xsd EX-101.SCH 5585
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230213_lab.xml EX-101.LAB 20934
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230213_pre.xml EX-101.PRE 12424
11 EXTRACTED XBRL INSTANCE DOCUMENT maia-8ka_20230213_htm.xml XML 4325
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41455 | Film No.: 23618361
SIC: 2834 Pharmaceutical Preparations